Reporting quality and risk of bias in JBI systematic reviews evaluating the effectiveness of interventions: a methodological review protocol.
Date
2023
Authors
Grammatopoulos, T.
Hunter, J.W.S.
Munn, Z.
Stone, J.C.
Barker, T.H.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
JBI Evidence Synthesis, 2023; 21(3):584-591
Statement of Responsibility
Tahlia Grammatopoulos, Jeremy W.S. Hunter, Zachary Munn, Jennifer C. Stone, Timothy Hugh Barker
Conference Name
Abstract
Objective: The objective of this methodological review is to evaluate the adherence of systematic reviews of effectiveness published in JBI Evidence Synthesis to reporting guidelines and methodological quality. Introduction: Systematic reviews of effectiveness are essential tools for health practitioners and policy-makers. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and the Risk of Bias in Systematic Reviews (ROBIS) tool are used to ensure maintenance of high reporting standards and methodological quality, respectively. This review will utilize these tools to identify strengths and shortfalls in the reporting quality of JBI systematic reviews of effectiveness. Inclusion criteria: This review will include the 20 most recent systematic reviews of effectiveness published in JBI Evidence Synthesis. Methods: This review will search MEDLINE (PubMed) for effectiveness reviews published in JBI Evidence Synthesis. Abstract and full-text screening will be performed by 2 independent reviewers, and the most recent 20 studies will be selected for inclusion. Data regarding adherence to PRISMA 2020 and ROBIS will be extracted by 2 independent reviewers. Data will be presented descriptively with tables and synthesized narratively.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2023 JBI.